These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 123935)

  • 21. In vivo sensitization of T cells to hapten-conjugated syngeneic structures of major histocompatibility complex. I. Effect of in vitro culture upon generation of cytotoxic T lymphocytes.
    Starzinski-Powitz A; Pfizenmaier K; Röllinghoff M; Wagner H
    Eur J Immunol; 1976 Nov; 6(11):799-805. PubMed ID: 1087237
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Lymphocyte-mediated cytotoxicity against allogeneic tumour cells. IV. Fine specificity mapping and characterization of concanavalin A-activated cytotoxic effector lymphocytes.
    Waterfield JD; Nixon DF; Mair MG
    Immunology; 1981 Dec; 44(4):685-93. PubMed ID: 6797935
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Radiosensitivity and responsiveness to recombinant interleukin-2 of effector cells of graft vs. host disease and mixed lymphocyte reaction in mice.
    Stark J; Weiss L; Slavin S
    Isr J Med Sci; 1992 Nov; 28(11):767-72. PubMed ID: 1468887
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cell types required for H-2-restricted cytotoxic responses generated by trinitrobenzene sulfonate-modified syngeneic cells or trinitrophenyl-conjugated proteins.
    Pettinelli CB; Schmitt-Verhulst AM; Shearer GM
    J Immunol; 1979 Mar; 122(3):847-54. PubMed ID: 87418
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Non-H-2-linked genetic control of murine cell-mediated lympholysis to autologous cells modified with fluorescein isothiocyanate (FTC-self).
    Arora PK; Shearer GM
    J Immunol; 1982 Sep; 129(3):1200-3. PubMed ID: 6809814
    [TBL] [Abstract][Full Text] [Related]  

  • 26. T cell responses induced by the parenteral injection of antigen-modified syngeneic cells. I. Induction, characterization, and regulation of antigen-specific T helper cells involved in delayed-type hypersensitivity responses.
    Miller SD; Butler LD
    J Immunol; 1983 Jul; 131(1):77-85. PubMed ID: 6190929
    [TBL] [Abstract][Full Text] [Related]  

  • 27. In vitro generation of suppressor cell activity: suppression of in vitro induction if cell-mediated cytotoxicity.
    Hodes RJ; Hathcock KS
    J Immunol; 1976 Jan; 116(1):167-77. PubMed ID: 128570
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The syngeneic T-T lymphocyte reaction (STTLR). II. Induction of primary T anti-T cell cytotoxic responses in vitro in T cell cultures stimulated with syngeneic self-reactive T cells.
    Suzuki H; Quintáns J
    J Mol Cell Immunol; 1986; 2(6):345-57. PubMed ID: 3509919
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Growth-dependent variation of major histocompatibility complex (MHC) restriction and expression of Ly-2 and CD3/alpha/beta T cell receptor in cloned cytotoxic T cells.
    Weltzien HU; Kempkes B; Studer R; Melchers I; Eichmann K
    Eur J Immunol; 1988 Mar; 18(3):431-7. PubMed ID: 2965649
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Specificity of cell-mediated cytotoxicity. II. Cytotoxic lymphocytes after in vitro allogeneic sensitization in the H-2 system].
    Schulze HA; Brock J
    Allerg Immunol (Leipz); 1983; 29(2):100-7. PubMed ID: 6224410
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Stimulation of mouse lymphocytes by a mitogen derived from Mycoplasma arthritidis. VI. Detection of a non-MHC gene(s) in the E alpha-bearing RIIIS mouse strain that is associated with a specific lack of T cell responses to the M. arthritidis soluble mitogen.
    Cole BC; Tuller JW; Sullivan GJ
    J Immunol; 1987 Aug; 139(3):927-35. PubMed ID: 3110289
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Induction and properties of cytotoxic T cells specific for hapten-coupled tumor cells.
    Dennert G; Hatlen LE
    J Immunol; 1975 Jun; 114(6):1705-12. PubMed ID: 805174
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Bifunctional major histocompatibility-linked genetic regulation of cell-mediated lympholysis to trinitrophenyl-modified autologous lymphocytes.
    Schmitt-Verhulst AM; Shearer GM
    J Exp Med; 1975 Oct; 142(4):914-27. PubMed ID: 52685
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Recognition and response to alloantigens in vivo. I. Negative and positive selection of MLR reactivity in murine peripheral blood lymphocytes to major histocompatibility complex and Mls antigens.
    Ryan JJ; Ahmed A; Kind PD; Thompson CB; Berning AK; Sell KW
    J Immunol; 1984 Aug; 133(2):606-15. PubMed ID: 6234352
    [TBL] [Abstract][Full Text] [Related]  

  • 35. T cell-accessory cell interactions that initiate allospecific cytotoxic T lymphocyte responses: existence of both Ia-restricted and Ia-unrestricted cellular interaction pathways.
    Singer A; Kruisbeek AM; Andrysiak PM
    J Immunol; 1984 May; 132(5):2199-209. PubMed ID: 6201534
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of hapten epitope structure and hapten-self conjugation pattern on T cell specificity and Ir gene control in hapten-self cytotoxic and helper T cell responses.
    Takai Y; Mizuochi T; Fujiwara H; Hamaoka T
    J Immunol; 1984 Jan; 132(1):57-62. PubMed ID: 6197460
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Reactivity of Ly-2+ T cells against 2,4,6-trinitrophenyl (TNP)-modified syngeneic stimulator cells: specificity, frequency of interleukin 2-producing Ly-2+ helper T cells and clonal segregation from Ly-2+ cytotoxic T lymphocytes.
    Schmitt J; Wagner H; Heeg K
    Eur J Immunol; 1988 Mar; 18(3):325-32. PubMed ID: 2965642
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Non-H-2-linked genetic regulation of cytotoxic responses to hapten-modified syngeneic cells. I. Non-H-2-linked Ir gene defect expressed on T cells is not predetermined at the stage of bone marrow cells.
    Ogata M; Shimizu J; Tsuchida T; Takai Y; Fujiwara H; Hamaoka T
    J Immunol; 1986 Feb; 136(4):1178-85. PubMed ID: 2935573
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cell-mediated immune responses to syngeneic tumors. I. Identification of two distinct CTL effector pathways which differ in antigen specificity, genetic regulation, and cell surface phenotype.
    Lynch DH; Daynes RA; Hodes RJ
    J Immunol; 1986 Feb; 136(4):1521-7. PubMed ID: 2418117
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Helper T cells against tumor-associated antigens (TAA): preferential induction of helper T cell activities involved in anti-TAA cytotoxic T lymphocyte and antibody responses.
    Fujiwara H; Yoshioka T; Shima J; Kosugi A; Itoh K; Hamaoka T
    J Immunol; 1986 Apr; 136(7):2715-9. PubMed ID: 3005417
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.